New team-based care guided by a personalized risk score for heart failure patients reduced the mortality rate of high-risk heart failure patients by nearly 50 percent, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.
Can your smart phone determine if you’re having the most serious – and deadly – form of heart attack? A new research study says it can – and may be a valuable tool to save lives.
Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City.
A new study presented at the American Heart Association Scientific Session conference has found that patients with atrial fibrillation (AF) also show signs of asymptomatic brain injury.
For patients who take medication to treat hypothyroidism, being treated with too much medication can lead to an increased risk of atrial fibrillation, a common heart rhythm disorder associated with stroke, a new study of more than 174,000 patients has found.
A new study presented at the American Heart Association Scientific Session conference found that testing a patient’s coronary calcium levels is a better predictor of blocked coronary arteries at risk for a heart attack and the need for revascularization than standard risk-assessment equations used in medical practice today.
A new nationwide study has found that a tiny clip placed in the heart to fix a leaky mitral valve drastically decreases the risk of both dying and returning to the hospital for heart failure patients.
The lives of two healthcare caregivers changed in two different, dramatic ways, thanks to generous organ donation.
Outdoor air pollution is a major contributor to indoor air pollution — but high-efficiency particulate air (HEPA) filters used in the home significantly reduce fine-particulate matter in the air compared with non-HEPA air filters, according to a new two-year study led by researchers at Intermountain Healthcare.
New study by researchers at Intermountain Medical Center in Salt Lake City found that patients with low-risk blood clots may be better off receiving treatment at home versus being admitted to the hospital.
Nonalcoholic fatty liver disease, or NAFLD, which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease.
Researchers are launching the first study of its kind involving up to 10,000 women that will use a new test to identify those at risk for premature birth, and, in those with high risk, to evaluate the impact of early interventions designed to prolong their pregnancy and reduce the rate of premature delivery.
National guidelines assume that all patients who’re diagnosed with clinical sepsis in an emergency department will be admitted to the hospital for additional care, but new research has found that many more patients are being treated and released from the ED for outpatient follow-up than previously recognized.
Researchers have developed a new tool that utilizes basic laboratory tests to effectively identify patients with chronic obstructive pulmonary disease who are at high risk of being hospitalized due to a flare up of the condition.
Atrial fibrillation patients who are diagnosed with carotid artery disease face higher risks for developing dementia, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.
Researchers have identified that enlargement of the left atrium of the heart is linked to abnormal activity of molecules that are associated with adverse changes in the heart’s size, shape, structure, and function — conditions that can lead to atrial fibrillation and death.
Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models more accurately helps clinicians assess the stroke risk of patients with Afib.
Researchers at Intermountain Healthcare and University of Utah Health in Salt Lake City have completed a study identifying how community hospitals with fewer than 200 beds can develop antibiotic stewardship programs that work to prevent the growth of antibiotic-resistant organisms, or “superbugs,” which are becoming more common and deadly.
Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3% of the diameter of human hair, is associated with the development of acute lower respiratory infection (ALRI) in young children, according to newly published research.
Two types of blood pressure medications — alpha blockers and alpha 2 agonist — show increased variability in blood pressure measurements between doctor visits, which is associated with an increased risk of death, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have found that incorporating underused, but available, imaging technologies, such as PET/CT scans, more precisely predicts who’s at risk for heart attacks and similar threats — in time to prevent them.
The stress of open-heart surgery significantly reduces patients’ vitamin D levels, but aggressive supplementation with vitamin D3, just before and after surgery, can completely eliminate the observed drop in vitamin D, researchers have found.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have found that incorporating underused, but available, imaging technologies more precisely predicts who’s at risk for heart attacks and similar threats — in time to prevent them.
Protein pathways that are closely linked to changes in both triglyceride and hemoglobin A1c levels in diabetic patients have been identified in new research by the Intermountain Medical Center Heart Institute in Salt Lake City.
Patients who undergo a transcatheter aortic valve replacement, or TAVR — a minimally-invasive surgical procedure that repairs a damaged heart valve — experienced a significant increase in their quality of life, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe obstructive coronary artery disease, according to researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Intermountain Healthcare is creating a new global DNA registry based on medical histories from people around the world, which researchers can use to find genetic codes that determine who’s at risk of developing genetic health problems and help them quickly and economically.
Mothers and babies belong together — which is why Intermountain Medical Center in Salt Lake City has launched a rooming-in program to support early bonding between mothers and newborns.
Intermountain Healthcare is spearheading a voluntary program that allows family members of patients to participate in their care —a program that has reduced 30-day readmission rates, according to a new study published in the February issue of the medical journal CHEST.
A clinical decision support application developed by Intermountain Healthcare researchers that more quickly identifies when heart failure becomes advanced and a heart patient’s care needs have changed is successful in helping to improve patient’s quality of live and longevity, according to a new study.
When a loved one has been hospitalized in intensive care for a critical illness, many family members experience anxiety, depression, post-traumatic stress or other negative effects lasting months, according to new research led by Intermountain Medical Center in Salt Lake City.
Individuals who have A, B, or AB blood types have an elevated risk of having a heart attack during periods of significant air pollution, compared to those with the O blood type, according to a new study from the Intermountain Medical Center Heart Institute and Brigham Young University.
While patients who are discharged from the hospital after treatment for heart disease, cerebrovascular disease, or peripheral artery disease, should be on statin medications to reduce their risk of reoccurrence, very few of them remain on the drugs long-term — and many never even receive a statin prescription, according to a new study.
Extreme ups and downs in systolic blood pressure may be just as deadly as having consistently high blood pressure, according to a new study from the Intermountain Medical Center Heart Institute in Salt Lake City.
Heart failure patients discharged from the hospital with a reduced level of a common hormone produced by the heart had significantly lower rates of readmission and lower death rates.
If you have a heart attack or stroke, it’s important to get your “bad” cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated with a reduced risk of suffering another serious cardiovascular episode.
Patients with a prior history of heart attacks or stroke have better outcomes when cholesterol-lowering medications are used after they’re discharged from the hospital, according to a new study from the Intermountain Medical Center Heart Institute in Salt Lake City.
A new five-year study of nearly 1,600 patients finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint replacement surgery.
Goal of new Intermountain Healthcare genomics study is to show whether screening patients for the presence of circulating tumor DNA, known as ctDNA, can successfully detect breast cancer using a blood draw.
Magnetic resonance imaging appears to be safe for patients with cardiac implantable electronic devices, even for chest imaging, according to a new study by researchers from the Intermountain Medical Center Heart Institute.
Patients who survive acute respiratory distress syndrome (ARDS) often leave a hospital intensive care unit with debilitating mental, physical, or cognitive problems that may limit their quality of life
People who are diagnosed with coronary artery disease and then develop depression face a risk of death that’s twice as high as heart patients without depression, according to a major new study by researchers at Intermountain Healthcare in Salt Lake City.
Many patients with melanoma need a sentinel-lymph-node biopsy to determine if cancer cells have spread there, but a positive finding doesn’t mean all the lymph nodes in the area must be removed, according to a new international study.
Patients with hepatitis C who suffer from advanced stages of liver disease have renewed hope, thanks to findings by researchers who have discovered that a new drug significantly reduces their risk of death and need for transplantation.
Despite many advancements in liver transplantation — like the cure for the hepatitis C virus — liver disease continues to impact people of all ages and cultures across the globe.
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who are considered to be at low risk for stroke may not be effective as previously thought.
A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than 2.7 million American adults.
Researchers have identified a microRNA biomarker that demonstrates a strong association with the incidence of atrial fibrillation, the most common abnormal heart rhythm.
Combining the Intermountain Mortality Risk Score (IMRS), developed by clinicians at Intermountain Healthcare, with the traditional CHA2DS2-VASc risk score, was more accurate in identifying at-risk patients than using the traditional score alone.
By combining a patient’s traditional risk score with the Intermountain Mortality Risk Score (IMRS), physicians and patients are better equipped to evaluate a patient’s individual risk of stroke, bleeding, and mortality with atrial fibrillation, according to a new study of more than 80,000 patients from the Intermountain Medical Center Heart Institute in Salt Lake City.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right